These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2700113

  • 1. [Effect of beta blockers with intrinsic sympathomimetic activity on blood pressure and blood lipids in patients with essential hypertension].
    Serro-Azul JB, Wajngarten M, Santomauro A, Braga A, Yazbek Júnior P, Bellotti G, Serro-Azul LG, Pileggi F.
    Arq Bras Cardiol; 1989 Dec; 53(6):321-5. PubMed ID: 2700113
    [Abstract] [Full Text] [Related]

  • 2. Effect of beta-blockers on plasma lipids.
    Pasotti C, Zoppi A, Capra A, Rebagliati M, Fogari R.
    Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):448-52. PubMed ID: 3759280
    [Abstract] [Full Text] [Related]

  • 3. Effects of chlorthalidone and metoprolol alone or in combination (logroton) on blood pressure, lipids, lipoproteins and circulating plasma ANF levels in essential hypertension.
    Bielmann P, Leduc G, Thibault G, Lepage J, Davignon J.
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):479-85. PubMed ID: 1839902
    [Abstract] [Full Text] [Related]

  • 4. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A.
    Blood Press Suppl; 1995 Dec; 3():38-46. PubMed ID: 8535541
    [Abstract] [Full Text] [Related]

  • 5. Plasma lipids during chronic antihypertensive therapy with different beta-blockers.
    Fogari R, Zoppi A, Pasotti C, Poletti L, Tettamanti F, Malamani G, Corradi L.
    J Cardiovasc Pharmacol; 1989 Dec; 14 Suppl 7():S28-32. PubMed ID: 2481787
    [Abstract] [Full Text] [Related]

  • 6. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ, Nanivadekar AS.
    J Assoc Physicians India; 1998 Dec; Suppl 1():52-62. PubMed ID: 11233387
    [Abstract] [Full Text] [Related]

  • 7. [Effects of calcium antagonist, angiotensin-converting enzyme inhibitors and beta-blocker on hemodynamic and sympathetic nerve responses to exercise in essential hypertension].
    Fujiwara S, Arita M, Ueno Y, Shiotani M, Nakatsu C, Nakamura Y, Hano T, Nishio I, Masuyama Y.
    J Cardiol; 1991 Dec; 21(1):115-24. PubMed ID: 1687786
    [Abstract] [Full Text] [Related]

  • 8. Effects of different beta-receptor antagonists on handgrip in essential hypertension.
    Fogari R, Marchesi E, Bellomo G, Parini A, Corradi L.
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):551-3. PubMed ID: 6129200
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [Abstract] [Full Text] [Related]

  • 10. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
    Bouvier JM, Rabot D, Herrero G.
    J Cardiovasc Pharmacol; 1990 Jan; 16 Suppl 5():S179-83. PubMed ID: 11527124
    [Abstract] [Full Text] [Related]

  • 11. [Activity and number of lymphocyte beta adrenergic receptors after protracted treatment with mepindolol sulfate of patients with essential arterial hypertension].
    Fabris B, De Biasi F, Fischetti F, Leprini R, Castellano M, Carretta R.
    G Clin Med; 1990 Nov; 71(11):639-44. PubMed ID: 1964919
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients.
    Derosa G, Cicero AF, Murdolo G, Piccinni MN, Fogari E, Bertone G, Ciccarelli L, Fogari R.
    Diabetes Obes Metab; 2005 Jan; 7(1):47-55. PubMed ID: 15642075
    [Abstract] [Full Text] [Related]

  • 13. Blood pressure reactivity in the evaluation of resting blood pressure and mood responses to pindolol and propranolol in hypertensive patients.
    Potempa KM, Fogg LF, Fish AF, Kravitz HM.
    Heart Lung; 1993 Jan; 22(5):383-91. PubMed ID: 8226001
    [Abstract] [Full Text] [Related]

  • 14. Effects of fosinopril on the blood pressure and lipid profile of patients undergoing heart transplantation.
    Almenar L, Osa A, Palencia M, Flores A, Sánchez E.
    J Heart Lung Transplant; 1997 Apr; 16(4):454-9. PubMed ID: 9154957
    [Abstract] [Full Text] [Related]

  • 15. Multicenter evaluation of mepindolol and of mepindolol plus hydrochlorothiazide in essential hypertension.
    Masoni A, Galassi A, Ginevrino P, Libretti A, Morgagni W, Rappelli A, Tomasi AM.
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):546-50. PubMed ID: 6757152
    [Abstract] [Full Text] [Related]

  • 16. Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial.
    Johnston GD, Vyssoulis G, Feely J, Holden RD, Radley DR.
    J Hum Hypertens; 1995 Feb; 9(2):123-9. PubMed ID: 7752174
    [Abstract] [Full Text] [Related]

  • 17. A comparison between metoprolol and pindolol in the treatment of essential hypertension.
    Tuomilehto J, Pohjola M.
    Ann Clin Res; 1978 Feb; 10(1):24-9. PubMed ID: 28070
    [Abstract] [Full Text] [Related]

  • 18. [Cardiovascular reactivity to isometric stress in patients with stable and borderline hypertension and in normotensive subjects. Effects of alpha sympatholytics and beta blocking agents].
    Colombo F, Porro T, Orlandi L, Borchini M, Libretti A.
    Cardiologia; 1990 Mar; 35(3):211-6. PubMed ID: 2245422
    [Abstract] [Full Text] [Related]

  • 19. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
    Yonga GO, Oyuga HW, Njeru EK.
    East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
    [Abstract] [Full Text] [Related]

  • 20. Beta-blocker effects on plasma lipids in antihypertensive therapy: importance of the duration of treatment and the lipid status before treatment.
    Fogari R, Zoppi A, Tettamanti F, Poletti L, Lazzari P, Pasotti C, Corradi L.
    J Cardiovasc Pharmacol; 1990 Jul; 16 Suppl 5():S76-80. PubMed ID: 11527140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.